Publications by authors named "Maria Tobena"

Claim this Profile
A
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Guillem Argilés, Nuria Mulet, Manuel Valladares-Ayerbes, José M Viéitez, Cristina Grávalos

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Maintenance Treatment in Metastatic Colorectal Cancer (mCRC): Quality and Clinical Benefit Overview.
Marta Martín-Richard, Maria Tobeña

J Clin Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype.
David Páez, María Tobeña, Julen Fernández-Plana, Ana Sebio, Anna C Virgili

Br J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.
Pau Riera, Anna C Virgili, Juliana Salazar, Ana Sebio, María Tobeña

Pharmacogenomics J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity.
Pau Riera, Juliana Salazar, Anna C Virgili, María Tobeña, Ana Sebio

Br J Clin Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer.
Cristina Grávalos, Alfredo Carrato, María Tobeña, Mercedes Rodriguez-Garrote, Gemma Soler

Clin Colorectal Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
Cristina Arqueros, Juliana Salazar, M J Arranz, Ana Sebio, Josefina Mora

Med Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients.
Ana Sebio, Laia Paré, David Páez, Juliana Salazar, Alan González

Pharmacogenet Genomics· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis